Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: results from the DREAM registry

類似資料

• Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry
  著者:: Vermeer, Marloes, 等
  出版事項: (2013)
• Recently diagnosed rheumatoid arthritis patients benefit from a treat-to-target strategy: results from the DREAM registry
  著者:: Steunebrink, Laura M. M., 等
  出版事項: (2016)
• Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort
  著者:: Vermeer, Marloes, 等
  出版事項: (2012)
• Radiographic progression in early rheumatoid arthritis patients following initial combination versus step-up treat-to-target therapy in daily clinical practice: results from the DREAM registry
  著者:: Steunebrink, Laura M. M., 等
  出版事項: (2018)
• Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
  著者:: Van De Laar, Celine J, 等
  出版事項: (2020)